Evidence map›Paper›PMID 33627169›Full record

Observational studyCritical care (London, England)2021

Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak.

Andrea Coppadoro, Annalisa Benini, Robert Fruscio, Luisa Verga, Paolo Mazzola, Giuseppe Bellelli, Marco Carbone, Giacomo Mulinacci, Alessandro Soria, Beatrice Noè and 11 more

Registry-linked trialOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in Critical care (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04424992 (Observational Cohort Study on the Natural History of Hospitalized SARS-COV-2 Patients), which is not on this map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
12.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04424992 recruitingnot on this map

Observational Cohort Study on the Natural History of Hospitalized SARS-COV-2 Patients: the STORM Trial

TypeobservationalSponsorUniversity of Milano BicoccaRan2020 to 2025Enrolled1,433ConditionsSars-CoV2ArmsObservational cohort study on the natural history of hospitalized SARS-COV-2 patients.
3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. CPAP delivered via a helmet interface in lightly sedated patients with moderate to severe ARDS: predictors of success outside the ICU.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2024
    Article
  9. ELMO CPAP: an innovative type of ventilatory support for COVID-19-related acute respiratory distress syndrome.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2024
    Article
  10. Observational
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Noninvasive Respiratory Assist Devices in the Management of COVID-19-related Hypoxic Respiratory Failure: Pune ISCCM COVID-19 ARDS Study Consortium (PICASo).Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 2 institutions in 1 country.

Andrea CoppadoroASST Monza, San Gerardo Hospital, Monza, Italy.
Annalisa BeniniASST Monza, San Gerardo Hospital, Monza, Italy.
Robert FruscioASST Monza, San Gerardo Hospital, Monza, Italy.
Luisa VergaASST Monza, San Gerardo Hospital, Monza, Italy.
Paolo MazzolaASST Monza, San Gerardo Hospital, Monza, Italy.
Giuseppe BellelliASST Monza, San Gerardo Hospital, Monza, Italy.
Marco CarboneASST Monza, San Gerardo Hospital, Monza, Italy.
Giacomo MulinacciASST Monza, San Gerardo Hospital, Monza, Italy.
Alessandro SoriaASST Monza, San Gerardo Hospital, Monza, Italy.
Beatrice NoèASST Monza, San Gerardo Hospital, Monza, Italy.
Eduardo BeckASST Monza, Desio Hospital, Desio, Italy.
Riccardo Di SciaccaASST Monza, San Gerardo Hospital, Monza, Italy.
Davide IppolitoASST Monza, San Gerardo Hospital, Monza, Italy.
Giuseppe CiterioASST Monza, San Gerardo Hospital, Monza, Italy.
Maria Grazia ValsecchiDepartment of Medicine and Surgery, University of Milan-Bicocca, Via Cadore 48, Monza, MB, Italy.
Andrea BiondiASST Monza, San Gerardo Hospital, Monza, Italy.
Alberto PesciASST Monza, San Gerardo Hospital, Monza, Italy.
Paolo BonfantiASST Monza, San Gerardo Hospital, Monza, Italy.
Davide GaudesiDepartment of Medicine and Surgery, University of Milan-Bicocca, Via Cadore 48, Monza, MB, Italy.
Giacomo Bellani *ASST Monza, San Gerardo Hospital, Monza, Italy. giacomo.bellani1@unimib.it.ORCID 0000-0002-3089-205X
Giuseppe Foti *ASST Monza, San Gerardo Hospital, Monza, Italy.
Azienda Ospedaliera San Gerardo · ITUniversity of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRespiratory failure due to COVID-19 pneumonia is associated with high mortality and may overwhelm health care systems, due to the surge of patients requiring advanced respiratory support. Shortage of intensive care unit (ICU) beds required many patients to be treated outside the ICU despite severe gas exchange impairment. Helmet is an effective interface to provide continuous positive airway pressure (CPAP) noninvasively. We report data about the usefulness of helmet CPAP during pandemic, either as treatment, a bridge to intubation or a rescue therapy for patients with care limitations (DNI).

methodsIn this observational study we collected data regarding patients failing standard oxygen therapy (i.e., non-rebreathing mask) due to COVID-19 pneumonia treated with a free flow helmet CPAP system. Patients' data were recorded before, at initiation of CPAP treatment and once a day, thereafter. CPAP failure was defined as a composite outcome of intubation or death.

resultsA total of 306 patients were included; 42% were deemed as DNI. Helmet CPAP treatment was successful in 69% of the full treatment and 28% of the DNI patients (P < 0.001). With helmet CPAP, PaO

conclusionsHelmet CPAP treatment is feasible for several days outside the ICU, despite persistent impairment in gas exchange. It was used, without escalating to intubation, in the majority of full treatment patients after standard oxygen therapy failed. DNI patients could benefit from helmet CPAP as rescue therapy to improve survival.

trial registrationNCT04424992.

Indexed as

Disease OutbreaksAgedContinuous Positive Airway PressureCOVID-19Feasibility StudiesFemaleHumansHypoxiaIntensive Care UnitsMaleMiddle AgedNoninvasive VentilationPneumonia, ViralTreatment OutcomeCoronavirus pneumoniaCovid-19Helmet continuous positive airways pressure CPAPNoninvasive ventilationPositive end expiratory pressure PEEP

Identifiers

PMID33627169
PMCPMC7903369
OpenAlexW3114333210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.